Several cohort studies and meta-analyses have observed the distinct pks+ E. coli-related signature in CRC patients [30,42], despite the fact that a pooled analysis of 3741 stool metagenomes did not clarify the precise developmental stage responsive to the impact of pks+ E. coli [43]. This evidence concerns the gene ARAF and colorectal carcinoma.